Steven Gillis, Director at Trubion Pharmaceuticals, Inc (TRBN), bought 44,640 shares at $13.00 ($580K) on 2006-10-18, disclosed to the SEC on 2006-10-20.
Open-market purchase of $580k TRBN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| BOLD | BUY | 2024-04-04 | $3.2M | — | Filing → |
| VBIV | BUY | 2023-07-18 | $2.0M | — | Filing → |
| CDAK | BUY | 2020-10-20 | $3.5M | — | Filing → |